Higher adherence to the Planetary Health Diet is linked to better executive function among older adults, according to data presented at EAN.

The FDA has approved Tryngolza (olezarsen) to reduce triglycerides and acute pancreatitis risk in adults with severe hypertriglyceridemia (TG ≥500mg/dL).

Women with suspected stroke are less likely than men to receive accurate prehospital stroke recognition, according to data presented at EAN.

Cannabinoid therapies may alleviate agitation in Alzheimer disease, though somnolence remains a primary safety concern.

Discover EAN findings on how biological sex influences Alzheimer disease-related neuropathology in patients with autopsy-confirmed Parkinson disease.

European Academy of Neurology 2026 coverage includes data on Alzheimer-related brain changes in patients with Parkinson Disease.

Actigraphy shows that many adults reporting short sleep duration actually sleep longer, highlighting the need for objective assessments.

Middle-aged adults with positive plasma biomarkers for Alzheimer disease show accelerated decline in specific cognitive domains.

Sexual and gender minority status in youth was associated with worse outcomes in chronic pain, which may be driven by psychologic distress.

The projected total cost of dementia for 2026 is around $818 billion, driven by quality-of-life losses among people with dementia.

Climate change and warmer weather may be driving an increase in ticks that carry a rare, high health consequence virus.

Topline data from the phase 3 Baby-COMET trial show avalglucosidase alfa met primary and secondary endpoints in infantile-onset Pompe disease.